OrganiGram Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $1.69
- Today's High:
- $1.89
- Open Price:
- $1.85
- 52W Low:
- $1.29
- 52W High:
- $5.08
- Prev. Close:
- $1.85
- Volume:
- 1115301
Company Statistics
- Market Cap.:
- $123.97 million
- Book Value:
- 3.752
- Revenue TTM:
- $161.08 million
- Operating Margin TTM:
- -25.75%
- Gross Profit TTM:
- $31.57 million
- Profit Margin:
- -137.67%
- Return on Assets TTM:
- -5.56%
- Return on Equity TTM:
- -54.53%
Company Profile
OrganiGram Holdings Inc had its IPO on 2014-08-27 under the ticker symbol OGI.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. OrganiGram Holdings Inc has a staff strength of 923 employees.
Stock update
Shares of OrganiGram Holdings Inc opened at $1.85 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $1.69 - $1.89, and closed at $1.76.
This is a -4.86% slip from the previous day's closing price.
A total volume of 1,115,301 shares were traded at the close of the day’s session.
In the last one week, shares of OrganiGram Holdings Inc have increased by +14.29%.
OrganiGram Holdings Inc's Key Ratios
OrganiGram Holdings Inc has a market cap of $123.97 million, indicating a price to book ratio of 0.778 and a price to sales ratio of 1.9272.
In the last 12-months OrganiGram Holdings Inc’s revenue was $161.08 million with a gross profit of $31.57 million and an EBITDA of $-15683000. The EBITDA ratio measures OrganiGram Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, OrganiGram Holdings Inc’s operating margin was -25.75% while its return on assets stood at -5.56% with a return of equity of -54.53%.
In Q1.6666666666667, OrganiGram Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 14%.
OrganiGram Holdings Inc’s PE and PEG Ratio
- Forward PE
- 28.9855
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-1.74 per share while it has a forward price to earnings multiple of 28.9855 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into OrganiGram Holdings Inc’s profitability.
OrganiGram Holdings Inc stock is trading at a EV to sales ratio of 1.5089 and a EV to EBITDA ratio of 20.0642. Its price to sales ratio in the trailing 12-months stood at 1.9272.
OrganiGram Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $348.52 million
- Total Liabilities
- $39.77 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $9.14 million
- Dividend Payout Ratio
- 0%
OrganiGram Holdings Inc ended 2024 with $348.52 million in total assets and $0 in total liabilities. Its intangible assets were valued at $348.52 million while shareholder equity stood at $301.99 million.
OrganiGram Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $39.77 million in other current liabilities, 775202000.00 in common stock, $-505615000.00 in retained earnings and $6.95 million in goodwill. Its cash balance stood at $52.72 million and cash and short-term investments were $53.04 million. The company’s total short-term debt was $80,000 while long-term debt stood at $100000.00.
OrganiGram Holdings Inc’s total current assets stands at $180.40 million while long-term investments were $14.73 million and short-term investments were $321000.00. Its net receivables were $35.78 million compared to accounts payable of $34.35 million and inventory worth $81.83 million.
In 2024, OrganiGram Holdings Inc's operating cash flow was $0 while its capital expenditure stood at $9.14 million.
Comparatively, OrganiGram Holdings Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $1.76
- 52-Week High
- $5.08
- 52-Week Low
- $1.29
- Analyst Target Price
- $2.25
OrganiGram Holdings Inc stock is currently trading at $1.76 per share. It touched a 52-week high of $5.08 and a 52-week low of $5.08. Analysts tracking the stock have a 12-month average target price of $2.25.
Its 50-day moving average was $1.5 and 200-day moving average was $2.44 The short ratio stood at 4.24 indicating a short percent outstanding of 0%.
Around 1900.7% of the company’s stock are held by insiders while 981.6% are held by institutions.
Frequently Asked Questions About OrganiGram Holdings Inc
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, gummies, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the SHRED, Big Bag O’ Buds, Monjour, SHRED’ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was incorporated in 2010 and is headquartered in Toronto, Canada.